| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MCW | Common Stock | Options Exercise | $49K | +74.3K | +98.4% | $0.66* | 150K | Jan 25, 2024 | Direct | |
| transaction | MCW | Common Stock | Sale | -$667K | -74.3K | -49.6% | $8.98 | 75.5K | Jan 25, 2024 | Direct | F1 |
| holding | MCW | Common Stock | 45K | Jan 25, 2024 | Emersyn Matheny Irrevocable Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MCW | Stock Option (Right to Buy) | Options Exercise | $0 | -74.3K | -40% | $0.00 | 111K | Jan 25, 2024 | Common Stock | 74.3K | $0.66 | Direct | F2 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.02. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option is fully vested and exercisable. |
The option exercises reported in Table II and the corresponding common stock sales reported in Table I of this Form 4 were executed pursuant to a 10b5-1 trading plan adopted on September 14, 2023.